| __timestamp | ACADIA Pharmaceuticals Inc. | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 189101000 |
| Thursday, January 1, 2015 | 73869000 | 96351000 |
| Friday, January 1, 2016 | 99284000 | 95967000 |
| Sunday, January 1, 2017 | 149189000 | 112171000 |
| Monday, January 1, 2018 | 187163000 | 182257000 |
| Tuesday, January 1, 2019 | 240385000 | 336964000 |
| Wednesday, January 1, 2020 | 319130000 | 547851000 |
| Friday, January 1, 2021 | 239415000 | 693716000 |
| Saturday, January 1, 2022 | 361575000 | 891813000 |
| Sunday, January 1, 2023 | 351619000 | 1044071000 |
| Monday, January 1, 2024 | 910408000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Exelixis, Inc. and ACADIA Pharmaceuticals Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Exelixis, Inc. consistently outspent ACADIA Pharmaceuticals Inc., with a notable peak in 2023 where Exelixis invested nearly three times more in R&D. This trend highlights Exelixis's aggressive strategy to maintain a competitive edge through innovation. Meanwhile, ACADIA Pharmaceuticals has shown a steady increase in R&D spending, with a significant 500% growth from 2014 to 2023. This suggests a strategic shift towards innovation, albeit at a more conservative pace. As the biotech industry continues to evolve, these spending patterns may influence future breakthroughs and market positions.
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
R&D Insights: How Exelixis, Inc. and CymaBay Therapeutics, Inc. Allocate Funds
Exelixis, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Research and Development Investment: Exelixis, Inc. vs Alkermes plc
R&D Insights: How Exelixis, Inc. and Amicus Therapeutics, Inc. Allocate Funds
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending